- DKK73.14bn
- DKK92.00bn
- DKK22.97bn
UBS cuts Demant to 'neutral' on limited upside to earnings forecasts
Morgan Stanley sees selective medtech opportunities on growth recovery
BofA double upgrades Demant on Zeal upside, market outlook
Demant's Q1 organic sales growth beat lifts shares 9%
Brief: Demant Q1 Group Organic Growth Of 6%
Sonova leads European hearing-care stocks lower after Cochlear warning
Jefferies cuts Amplifon, GN on hearing business deal
Europe Research Roundup: Demant, TotalEnergies, Yara
Amplifon tumbles as pricey GN Hearing deal indicates business shift
Brief: Demant Board Elects Kristian Villumsen As Chairperson
Sonova expects FY revenue at lower end of target range, CEO says in interview
Europe Research Roundup: Glencore, Nordic Semiconductor, Wizz
Europe Research Roundup: Berkeley Group, Next 15 Group, Westwing Group
Demant slumps as disappointing 2026 forecasts dwarf Q4 beat
Brief: Demant Sees 2026 EBIT Before Special Items Of DKK 4.1-4.5 Bln
Brief: Demant Board Intends To Appoint Kristian Villumsen As New Chair
Brief: Demant Sells EPOS To ACCO Brands
Europe Research Roundup: Edenred, Outokumpu, UBS Group
BNP picks medtech favourites, sees re-rating in H2 2026